Vimarsana
Biggest News Aggregation in the World

Page 3 - Therapeutics Task News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutics Task. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutics Task Today - Breaking & Trending Today

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 - Vimarsana News

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Share Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial. PRINCIPLE is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treatment for use in the community that can significantly shorten recovery time. As one of the UK Government’s national priority platform trials,...

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home - Vimarsana News

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home

Share This The FINANCIAL --  Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings. The Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial is led by the University of Oxford. It is funded by UK Research and Innovation and the National Institute for Health Research (NIHR) through the COVID-19 Rapid Response rolling call. It is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treat...

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 - Vimarsana News

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Date Time Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK’s PRINCIPLE trial in 1,779 participants. Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Pla...

Washtenaw County receives extra 2,500 COVID vaccine doses for most vulnerable residents - Vimarsana News

Washtenaw County receives extra 2,500 COVID vaccine doses for most vulnerable residents

Washtenaw County receives extra 2,500 COVID vaccine doses for most vulnerable residents Health Department to host several vaccine pop-ups in church, community settings Meredith Bruckner, Community News Producer, All About Ann Arbor Published:  Updated:  Tags:  FILE - In this file photo dated Wednesday, Feb. 17, 2021, three vials of the Moderna COVID-19 Vaccine are pictured in a new coronavirus vaccination center at the 'Velodrom' (velodrome-stadium) in Berlin, Germany. Slow off the blocks in the race to immunize its citizens against COVID-19, Germany faces the problem of having a glut of v...

Major investments in domestic firms to rebuild Canada's biomanufacturing sector - Vimarsana News

Major investments in domestic firms to rebuild Canada's biomanufacturing sector

Share this article Government of Canada investments will help advance made-in-Canada vaccines and therapeutics for COVID-19   OTTAWA, ON, March 16, 2021 /CNW/ - Canadians have demonstrated a remarkable ability to mobilize in response to the COVID–19 pandemic. Companies in the biomanufacturing space from coast to coast to coast have answered the call, and the government wants to recognize their work. To date, the Government of Canada has made investments of approximately $1 billion to advance industrial research and development in vaccines and pharmaceuticals, as well as biomanufactu...